These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31898342)

  • 1. Transcription factor RUNX3 promotes CD8
    Song Q; Shang J; Zhang C; Chen J; Zhang L; Wu X
    J Cell Biochem; 2020 Jun; 121(5-6):3208-3220. PubMed ID: 31898342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma.
    Miyashita N; Horie M; Mikami Y; Urushiyama H; Fukuda K; Miyakawa K; Matsuzaki H; Makita K; Morishita Y; Harada H; Backman M; Lindskog C; Brunnström H; Micke P; Nagase T; Saito A
    Cancer Lett; 2020 Oct; 489():121-132. PubMed ID: 32534174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-301a promotes lung tumorigenesis by suppressing Runx3.
    Li X; Zhong M; Wang J; Wang L; Lin Z; Cao Z; Huang Z; Zhang F; Li Y; Liu M; Ma X
    Mol Cancer; 2019 May; 18(1):99. PubMed ID: 31122259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HES6 Mediates Oxidative Phosphorylation Pathway to Promote Immune Infiltration of CD8 + T Cells in Lung Adenocarcinoma.
    Chen Z; Wang Y; Tang W; Xu S; Yu H; Chen Z
    J Immunother; 2024 Oct; 47(8):313-322. PubMed ID: 39005046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
    Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
    Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
    Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y
    Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-cell-secreted CXCL11 promoted CD8
    Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
    J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL5 impedes CD8
    Sun D; Tan L; Chen Y; Yuan Q; Jiang K; Liu Y; Xue Y; Zhang J; Cao X; Xu M; Luo Y; Xu Z; Xu Z; Xu W; Shen M
    J Exp Clin Cancer Res; 2024 Jul; 43(1):202. PubMed ID: 39034411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer.
    Kim HJ; Park J; Lee SK; Kim KR; Park KK; Chung WY
    J Pathol; 2015 Dec; 237(4):520-31. PubMed ID: 26239696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
    Yuan L; Wu X; Zhang L; Yang M; Wang X; Huang W; Pan H; Wu Y; Huang J; Liang W; Li J; Zhu X; Wang S; Guan J; Liu L
    Cancer Immunol Immunother; 2022 Feb; 71(2):399-415. PubMed ID: 34181042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
    Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
    Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition.
    Fan T; Li S; Xiao C; Tian H; Zheng Y; Liu Y; Li C; He J
    Int J Biol Sci; 2022; 18(11):4275-4288. PubMed ID: 35864953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of baseline CCL19
    Zhu M; Wang B; Zhang X; Zhou K; Miao Z; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug; 44(8):1529-1536. PubMed ID: 39276048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy.
    Liu Z; Li X; Gao Y; Liu J; Feng Y; Liu Y; Wang J; Wang C; Wang D; He J; Han W; Mei Q; Sun Y
    Mol Cancer; 2023 May; 22(1):84. PubMed ID: 37189103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.